188 related articles for article (PubMed ID: 17412975)
21. Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization.
Chen HW; Leng CH; Liu HY; Cheng WF; Chang YW; Wu PY; Lien SP; Huang TY; Chiang SK; Lin MH; Tao MH; Chong P; Liu SJ
Cancer Biol Ther; 2009 Nov; 8(21):2025-32. PubMed ID: 19738415
[TBL] [Abstract][Full Text] [Related]
22. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
Gu Y; Wei M; Wang D; Li Z; Xie M; Pan H; Wu T; Zhang J; Li S; Xia N
Vaccine; 2017 Aug; 35(35 Pt B):4637-4645. PubMed ID: 28736197
[TBL] [Abstract][Full Text] [Related]
23. HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein.
Nakagawa M; Kim KH; Gillam TM; Moscicki AB
J Virol; 2007 Feb; 81(3):1412-23. PubMed ID: 17108051
[TBL] [Abstract][Full Text] [Related]
24. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
Yang Y; Che Y; Zhao Y; Wang X
Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responses.
van den Hende M; Redeker A; Kwappenberg KM; Franken KL; Drijfhout JW; Oostendorp J; Valentijn AR; Fathers LM; Welters MJ; Melief CJ; Kenter GG; van der Burg SH; Offringa R
J Infect Dis; 2010 Oct; 202(8):1200-11. PubMed ID: 20822453
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
27. Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
Khan S; Oosterhuis K; Wunderlich K; Bunnik EM; Bhaggoe M; Boedhoe S; Karia S; Steenbergen RDM; Bosch L; Serroyen J; Janssen S; Schuitemaker H; Vellinga J; Scheper G; Zahn R; Custers J
Int J Cancer; 2017 Jul; 141(2):393-404. PubMed ID: 28263390
[TBL] [Abstract][Full Text] [Related]
28. Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18.
Smith KL; Tristram A; Gallagher KM; Fiander AN; Man S
Int Immunol; 2005 Feb; 17(2):167-76. PubMed ID: 15623547
[TBL] [Abstract][Full Text] [Related]
29. Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.
James EA; DeVoti JA; Rosenthal DW; Hatam LJ; Steinberg BM; Abramson AL; Kwok WW; Bonagura VR
J Immunol; 2011 Jun; 186(11):6633-40. PubMed ID: 21531896
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7.
Tsang KY; Fantini M; Fernando RI; Palena C; David JM; Hodge JW; Gabitzsch ES; Jones FR; Schlom J
Vaccine; 2017 May; 35(19):2605-2611. PubMed ID: 28389098
[TBL] [Abstract][Full Text] [Related]
31. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
[TBL] [Abstract][Full Text] [Related]
32. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
34. Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009.
Pellom ST; Smalley Rumfield C; Morillon YM; Roller N; Poppe LK; Brough DE; Sabzevari H; Schlom J; Jochems C
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33651712
[TBL] [Abstract][Full Text] [Related]
35. A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.
Huber B; Schellenbacher C; Jindra C; Fink D; Shafti-Keramat S; Kirnbauer R
PLoS One; 2015; 10(3):e0120152. PubMed ID: 25790098
[TBL] [Abstract][Full Text] [Related]
36. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Johnson LE; McNeel DG
Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
[TBL] [Abstract][Full Text] [Related]
37. Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8
Krishna S; Ulrich P; Wilson E; Parikh F; Narang P; Yang S; Read AK; Kim-Schulze S; Park JG; Posner M; Wilson Sayres MA; Sikora A; Anderson KS
Cancer Res; 2018 Nov; 78(21):6159-6170. PubMed ID: 30154146
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
Welters MJ; van der Logt P; van den Eeden SJ; Kwappenberg KM; Drijfhout JW; Fleuren GJ; Kenter GG; Melief CJ; van der Burg SH; Offringa R
Int J Cancer; 2006 Feb; 118(4):950-6. PubMed ID: 16152582
[TBL] [Abstract][Full Text] [Related]
39. A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.
Wang X; Santin AD; Bellone S; Gupta S; Nakagawa M
Cancer Immunol Immunother; 2009 Feb; 58(2):301-8. PubMed ID: 18446336
[TBL] [Abstract][Full Text] [Related]
40. Analysis of HLA-DRB1*0901-binding HPV-16 E7 helper T cell epitope.
Okubo M; Saito M; Inoku H; Hirata R; Yanagisawa M; Takeda S; Kinoshita K; Maeda H
J Obstet Gynaecol Res; 2004 Apr; 30(2):120-9. PubMed ID: 15009616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
